These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Enhanced expression of a recombinant malaria candidate vaccine in Escherichia coli by codon optimization. Zhou Z, Schnake P, Xiao L, Lal AA. Protein Expr Purif; 2004 Mar 30; 34(1):87-94. PubMed ID: 14766303 [Abstract] [Full Text] [Related]
31. Microparticle-mediated gene delivery for the enhanced expression of a 19-kDa fragment of merozoite surface protein 1 of Plasmodium falciparum. Liu S, Danquah MK, Forde GM, Ma C, Wang L, Coppel R. Biotechnol Prog; 2010 Mar 30; 26(1):257-62. PubMed ID: 19924768 [Abstract] [Full Text] [Related]
32. New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin. Bargieri DY, Rosa DS, Braga CJ, Carvalho BO, Costa FT, Espíndola NM, Vaz AJ, Soares IS, Ferreira LC, Rodrigues MM. Vaccine; 2008 Nov 11; 26(48):6132-42. PubMed ID: 18804504 [Abstract] [Full Text] [Related]
38. Expression and purification of Plasmodium falciparum MSP-1(42): A malaria vaccine candidate. Epp C, Kauth CW, Bujard H, Lutz R. J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Mar 25; 786(1-2):61-72. PubMed ID: 12651002 [Abstract] [Full Text] [Related]
39. Production, characterization, and immunogenicity of a secreted form of Plasmodium falciparum merozoite surface protein 4 produced in Bacillus subtilis. Chittibabu G, Ma C, Netter HJ, Noronha SB, Coppel RL. Appl Microbiol Biotechnol; 2014 Apr 25; 98(8):3669-78. PubMed ID: 24146077 [Abstract] [Full Text] [Related]
40. Limited allelic diversity of Plasmodium falciparum merozoite surface protein 1 gene from populations in the Solomon Islands. Sakihama N, Ohmae H, Bakote'e B, Kawabata M, Hirayama K, Tanabe K. Am J Trop Med Hyg; 2006 Jan 25; 74(1):31-40. PubMed ID: 16407343 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]